KRT80 and lung adenocarcinoma: Yuting et al found that the expression of KRT80 in NSCLC tissues was higher than that in adjacent normal tissues of patients, and the overexpression rate of KRT80 in lung adenocarcinoma (LUAD) tissues was significantly higher than that in lung squamous cell carcinoma (LUSC) tissues, based on the immunocytochemistry assays of 176 patients.29